Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients with Advanced Hormone Refractory Prostate CancerCIRB: Adult CIRB - Late Phase EmphasisLead Group: SWOGStatus: CompletedReview Status: Completed
